Association between serum paraoxonase activity and oxidative stress in acute coronary syndromes

References

• Witztum J, Steinberg D. The oxidative modification hypoth-esis of atherosclerosis: does it hold for humans? Trends Cardiovasc Med 2001; 11: 93–102.
   Google Scholar
• Fuhrman B, Aviram M. Preservation of paraoxonase activity by wine flavanoids: possible role in protection of LDL from lipid peroxidation. Ann NY Acad Sci 2002; 957: 321–4.
   Google Scholar
• Hattori Y, Suzuki M, Tsushima M, Yoshida M, Tokunaga Y, Wang. Zhao D, Takeuchi M, Hara Y, Ryomoto KI, Ikebuchi M, Kishioka H, Mannami T, Baba S, Harano Y Development of approximate formula for LDL-chol, LDL-apo B and LDL-chol/LDL-apo B as indices of hyperapo-betalipoproteinemia and small dense LDL. Atherosclerosis 1998; 138: 289–99.
   Google Scholar
• Graaf J, Hendriks JCM, Demacker PNM, Stalenhoef AFH. Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hyper-triglyceridemic subjects. Arterioscler Thromb 1993; 13: 712–9.
   Google Scholar
• Li LH, Liu DP, Liang CC. Paraoxonase gene polymor-phism, oxidative stress and disease. J Mol Med 2003; 81: 766–79.
   Google Scholar
• Tward A, Xia YR, Wang XP, Shi YS, Park C, Castellani LW, Lusis AJ, Shih DM. Decreased atherosclerotic lesion for-mation in human serun paraoxonase transgenic mice. Circulation 2002; 106: 484–90.
   Google Scholar
• Oda MN, Bielicki JK, Ho TT, Berger T, Rubin EM, Forte TM. Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins. Biochem Biophys Res Commun 2002; 290: 921–7.
   Google Scholar
• Shih DM, Gu L, Xia YR, Navab M, Li WF, Hama S, Castel-lani LW, Furlong CE, Costa LG, Fogelman AM, Lusis AR. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 1998; 394: 284–7.
   Google Scholar
• Mackness MI, Arrol S, Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 1991; 286: 152–4.
   Google Scholar
• Aviram M, Rosenblat NT, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: a possible peroxidative role for paraoxonase. J Clin Invest 1998; 101: 1581–90.
   Google Scholar
• McErlean ES, Deluca SA, Van Lente F, Peacock F, Rao JS, Balog CA, Nissen SE. Comparison of troponin-T versus creatine kinase-MB in suspected acute coronary syndromes. Am J Cardiol 2000; 85: 421–6.
   Google Scholar
• Mueller RF, Hornung S, Furlong CE, Anderson J, Giblett ER, Motulsky AG. Plasma paraoxonase polymor-phism: a new enzyme assay, population, family, biochemical and linkage studies. Am J Hum Genet 1983; 35: 393–408.
   Google Scholar
• Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Granjean P. Plasma malondialdehyde as biomarker for oxidative stress: reference intervals and effects of life-style factors. Clin Chem 1997; 43: 1209–14.
   Google Scholar
• Liu K, Cuddy TE, Pierce GN. Oxidative status of lipopro-teins in coronary disease patients. Am Heart J 1992; 123: 285–9.
   Google Scholar
• Ganz P, Behrendt D. Endothelial function: from vascular biology to clinical applications. Am J Cardiol 2002; 90 suppl: 40L–48L.
   Google Scholar
• Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms: oxidation, inflammation, and genetics. Circu-lation 1995; 91: 2488–96.
   Google Scholar
• Aviram M. Review on human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Rad Res 2000; 33: S85–97.
   Google Scholar
• Krentz AJ. Lipoprotein abnormalities and their conse-quences for patients with type 2 diabetes. Diabetes Obes Metab 2003; 5 suppl 1: S19–27.
   Google Scholar
• Navab M, Berliner JA, Subbanagounder G, Hama S, Lusis AJ, Castellani LW. Reddy S, Shih D, Shi W, Watson AD, Van Lenten BJ, Vora D, Fogelman AM. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler Thromb Vasc Biol 2001; 21: 481–8.
   Google Scholar
• Watson AD, Berliner JA, Hama SY, LaDu BN, Faull KF, Fogelman AM, Navab M. Protective effect of high density lipoprotein associated paraoxonase. J Clin Invest 1995; 96: 2882–91.
   Google Scholar
• Durrington PN, Mackness B, Mackness MI. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21: 473–80.
   Google Scholar
• Shih DM, Xia YR, Wang XP, Miller E, Castellani LW, Subbanagounder G, Cheroutre H, Faull KF, Berliner JA, Witztum JL, Lusis AJ. Combined serum paraoxonase knock-out/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J Biol Chem 2000; 275: 17527–35.
   Google Scholar
• Ayub A, Mackness MI, Arrol S, Mackness B, Patel J, Durrington PN. Serum paraoxonase after myocardial infarction. Arterioscler Thromb Vasc Biol 1999; 19: 330–5.
   Google Scholar
• Mackness MI, Arrol S, Abbott CA, Durrington PN. Protection of low-density lipoprotein against oxidative mod-ification by high-density lipoprotein associated paraoxonase. Atherosclerosis 1993; 104: 129–35.
   Google Scholar
• Mackness MI, Mackness B, Durrington PN, Connelly PW, Hegele RA. Paraoxonase: biochemistry, genetics and rela-tionship to plasma lipoproteins. Curr Opin Lipidol 1996; 7: 69–76.
   Google Scholar
• Mackness MI, Harty D, Bhatnagar D, Winocour PH, Arrol S, Ishola M, Durrington PN. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-depen-dent diabetes mellitus. Atherosclerosis 1991; 86: 193–8.
   Google Scholar
• Rosenblat M, Grunfeld O, Hayek T, Aviram M. Serum paraoxonase activity and the extent of lipid peroxidation are not affected by increased levels of human apolipprotein A-1: studies in transgenic mice. Clin Chem Lab Med 2002; 40: 9–14.
   Google Scholar
• James RW, Leviev I, Righetti A. Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease. Circulation 2000; 101: 2252–7.
   Google Scholar
• Jarvik GP, Tsai NT, McKinstry LA, Wani R, Brophy VH, Richter RJ, Schellengerberg GD, Heagerty PJ, Hatsukami TS, Furlong CE. Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler Thromb Vasc Biol 2002; 22: 1329–33.
   Google Scholar
• Oliveira SA, Mansur AP, Ribiero CC, Ramires JAF, Annichino-Bizzacchi JM. PON1 M/L55 mutation protects high-risk patients against coronary artery disease. Int J Car-diol 2004; 94: 73–7.
   Google Scholar
• Robertson KS, Hawe E, Miller GJ, Talmud PJ, Humphries SE. Human paraoxonase gene cluster polymor-phisms as predictors of coronary heart disease risk in the prospective Northwick Park Heart Study II. Biochim Bio-phys Acta 2003; 1639: 203–12.
   Google Scholar
• Van Lenten BJ, Hama SY, de Beer FC, Stafforini DM, McIntyre TM, Prescott SM, La Du BN, Fogelman AM, Navab M. Anti-inflamatory HDL becomes pro-inflamatory during the acute phase response. J Clin Invest 1995; 96: 2758–67.
   Google Scholar
• Feingold KR, Memon RA, Moser AH, Grunfeld C. Paraox-onase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis 1998; 139: 307–15.
   Google Scholar